Brekiya Injection
Product Images NDC 64896-509

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Brekiya (NDC 64896-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 1)

Dihydroergotamine mesylate is a medication used for the treatment of migraines. It is a semi-synthetic form of ergot alkaloids and works by constricting blood vessels in the brain. This can help reduce the intensity of migraine headaches.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 10)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 11)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 12)

This text indicates the steps for removing the needle cap from a device. The safety guard should be pulled off first, followed by removing the red needle cap, which is to be discarded.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 13)

This is a straight position at a 90-degree angle.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 14)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 15)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 16)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 17)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 18)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 19)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 2)

This is a description of a medication called Brekiya, specifically a dihydroergotamine mesylate injection with a concentration of 1 mg/mL. It is presented in an autoinjector format for convenient and easy administration.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 20)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 21)

This is a description of Brekiya® autoinjector, which contains dihydroergotamine mesylate for subcutaneous injection. Each mL prefilled single-dose autoinjector consists of 1 mg of dihydroergotamine mesylate, alcohol, glycerin, and water for injection. The pH range is adjusted to between 3.4 and 4.9. The product is distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC, located in Bridgewater, NJ. The medication is manufactured in India.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 22)

This text is a medication label for Brekiya, a dihydroergotamine mesylate injection in 1 mg/mL concentration. The medication comes in a prefilled single-dose autoinjector for subcutaneous injection. It contains 1 mg of dihydroergotamine mesylate, alcohol, glycerin, water for injection, and pH adjusters. The storage temperature ranges from 20°C to 25°C, with excursions permitted between 15°C to 30°C. It warns not to refrigerate or freeze the medication and keep it protected from light. Caution is also provided about potential allergic reactions from the needle cover. The medication is manufactured in India and distributed by Amneal Specialty, a division of Amneal Pharmaceuticals in the USA.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 23)

This text appears to be a detailed description of a medication product called "Brekiya," which is an autoinjector containing dihydroergotamine mesylate injection at a concentration of 1 mg/mL, designed for subcutaneous injection. The text includes information on the manufacturer, caution regarding the needle cover containing dry natural rubber/latex, and instructions for use. The product is distributed by Amneal Specialty, a division of Amneal Pharmaceuticals LLC. The text also provides details such as the NDC number, manufacturing location in India, and information on the packaging and expiration date.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 3)

This text provides information about BREKIYA, which is a medication containing dihydroergotamine mesylate, intended for subcutaneous injection.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 4)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 5)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 6)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 7)

This text appears to be a list of components or items related to an autoinjector device, including alcohol wipes, a sharps container, and a pouch for storage. It seems to be a simple guide or inventory for the device.*

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 8)

FDA Label Image

1 (Brekiya Dihydroergotamine Mesylate Injection 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.